ALK to present at two upcoming 2015 Investor Conferences
May 27, 2015 09:04 ET
|
ALK Abello
Copenhagen, 2015-05-27 15:04 CEST (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the Company will present at the Jefferies 2015 Global Healthcare...
Three-month interim report (Q1) 2015
May 05, 2015 01:45 ET
|
ALK Abello
København, 2015-05-05 07:45 CEST (GLOBE NEWSWIRE) --
Bemærk venligst, at kvartalsrapporten kun foreligger på engelsk.
Performance for the period (unaudited)
(Comparative figures for 2014...
Three-month interim report (Q1) 2015
May 05, 2015 01:45 ET
|
ALK Abello
Copenhagen, 2015-05-05 07:45 CEST (GLOBE NEWSWIRE) --
Performance for the period (unaudited)
(Comparative figures for 2014 are shown in brackets / revenue growth is measured in local...
ALK og bioCSL indgår partnerskab i Australien og New Zealand
February 09, 2015 03:00 ET
|
ALK Abello
København, 2015-02-09 09:00 CET (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) og bioCSL meddeler, at de har indgået et partnerskab for Australien og New Zealand....
ALK and bioCSL enter into a partnership for allergy
February 09, 2015 03:00 ET
|
ALK Abello
Copenhagen, 2015-02-09 09:00 CET (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) and bioCSL announce a partnership in Australia and New Zealand which grants bioCSL exclusive...
New PSA Reminds College Students That Vaccination Is the Best Form of Protection Against Dangerous Flu Virus
November 25, 2014 03:00 ET
|
bioCSL
KING OF PRUSSIA, PA--(Marketwired - Nov 25, 2014) - Although the Centers for Disease Control and Prevention (CDC) recommends that everyone six months of age and older get a flu vaccine every...
Novartis announces divestiture of influenza vaccines business to CSL for USD 275 million
October 26, 2014 17:00 ET
|
Novartis Pharma AG
CSL to acquire Novartis influenza vaccines business, including development pipeline, for USD 275 million Announcement follows a transaction announced on April 22, 2014 to divest the...
Novartis announces divestiture of influenza vaccines business to CSL for USD 275 million
October 26, 2014 17:00 ET
|
NOVARTIS FINANCE S.A.
CSL to acquire Novartis influenza vaccines business, including development pipeline, for USD 275 million Announcement follows a transaction announced on April 22, 2014 to divest the...
Nation's largest distributor of influenza vaccines prepared to respond to vaccine delays
October 13, 2014 12:48 ET
|
FFF Enterprises
TEMECULA, Calif., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Unexpected delays from multiple manufacturers are causing postponements of flu shipments to some healthcare providers who are just beginning their...
FDA Approves the Use of a Needle-Free Injection Device to Administer the Influenza Vaccine
September 16, 2014 10:18 ET
|
Eternity Healthcare, Inc.
PHOENIX and VANCOUVER, British Columbia, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Eternity Healthcare Inc. (OTC:ETAH), a medical device and diagnostic company with advanced technologies using the...